Glaukos Corp (GKOS): Cash & Equivalents
$90.81M
As of 2025-12-31
$114.48M
As of 2026-06-30
-8.8%
3-year compound annual growth
-1.2%
5-year compound annual growth
+15.5%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $90.81M | -46.5% | 2026-02-23, Balance as of period end |
| 2024-12-31 | $169.63M | +81.5% | 2026-02-23, Balance as of period end |
| 2023-12-31 | $93.47M | -21.8% | 2026-02-23, Balance as of period end |
| 2022-12-31 | $119.53M | +18.7% | 2025-02-25, Balance as of period end |
| 2021-12-31 | $100.71M | +4.3% | 2024-02-23, Balance as of period end |
| 2020-12-31 | $96.60M | +54.7% | 2023-02-24, Balance as of period end |
| 2019-12-31 | $62.43M | +109.3% | 2022-02-28, Balance as of period end |
| 2018-12-31 | $29.82M | +21.7% | 2021-03-01, Balance as of period end |
| 2017-12-31 | $24.51M | +277.4% | 2020-03-02, Balance as of period end |
| 2016-12-31 | $6.49M | -69.9% | 2018-02-28, Balance as of period end |
| 2015-12-31 | $21.57M | +836.3% | 2018-02-28, Balance as of period end |
| 2014-12-31 | $2.30M | -65.8% | 2017-03-15, Balance as of period end |
| 2013-12-31 | $6.73M | n/a | 2016-03-15, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Glaukos Corp (GKOS) | 2025-12-31 | $90.81M | -46.5% |
| AtriCure, Inc. (ATRC) | 2025-12-31 | $167.43M | +36.4% |
| Bioventus Inc. (BVS) | 2025-12-31 | $51.24M | +23.2% |
| Artivion, Inc. (AORT) | 2025-12-31 | $64.91M | +21.4% |
| UFP Technologies Inc (UFPT) | 2025-12-31 | $20.30M | +50.9% |
| Mimedx Group, Inc. (MDXG) | 2025-12-31 | $166.12M | +59.1% |
| Accuray Inc (ARAY) | 2026-06-30 | $40.62M | -29.2% |
| NovoCure Ltd (NVCR) | 2025-12-31 | $93.55M | -42.9% |
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $236.01M | -43.8% |
Compare GKOS, ATRC, BVS, AORT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗